Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.
- NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_assertion description "[In combination with paclitaxel, anti-PLK-1 siRNA chemosensitized non-small cell lung cancer (NSCLC) and prostate carcinoma cell lines, leading up to a 2-fold increase in the drug cytotoxic effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.
- NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_assertion evidence source_evidence_literature NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.
- NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_assertion SIO_000772 23531193 NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.
- NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_assertion wasDerivedFrom befree-20150227 NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.
- NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_assertion wasGeneratedBy ECO_0000203 NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP630899.RAhQfm6Iod6tuslXRTc3biiukVvY68c-Q7S0qpn6W1cAc130_provenance.